Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study Evaluating Bifeprunox in Bipolar Depression

ClinicalTrials.gov ID: NCT00245973

Public ClinicalTrials.gov record NCT00245973. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 10:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Bifeprunox in the Treatment of Depression in Outpatients With Bipolar Disorder

Study identification

NCT ID
NCT00245973
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Industry
Enrollment
380 participants

Conditions and interventions

Interventions

  • Bifeprunox Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2005
Primary completion
Not listed
Completion
Sep 30, 2007
Last update posted
Dec 4, 2007

2005 – 2007

United States locations

U.S. sites
40
U.S. states
25
U.S. cities
39
Facility City State ZIP Site status
Not listed Birmingham Alabama 35216
Not listed Beverly Hills California 90210
Not listed National City California 91950
Not listed Stanford California 94305
Not listed Farmington Hills Connecticut 06030
Not listed Bradenton Florida 34208
Not listed Jacksonville Florida 32216
Not listed Orlando Florida 32806
Not listed West Palm Beach Florida 33407
Not listed Smyrna Georgia 30080
Not listed Honolulu Hawaii 96826
Not listed Terre Haute Indiana 47802
Not listed Florence Kentucky 41042
Not listed New Orleans Louisiana 70115
Not listed Rockville Maryland 20852
Not listed Boston Massachusetts 02114
Not listed Farmington Hills Michigan 48336
Not listed Saint Charles Missouri 63301
Not listed Clementon New Jersey 08021
Not listed Moorestown New Jersey 08057
Not listed Lawrence New York 11559
Not listed New York New York 10021
Not listed New York New York 10024
Not listed Staten Island New York 10305
Not listed The Bronx New York 10467
Not listed Winston-Salem North Carolina 27103
Not listed Cincinnati Ohio 45242
Not listed Dayton Ohio 45408
Not listed Lyndhurst Ohio 44124
Not listed Oklahoma City Oklahoma 73103
Not listed Tulsa Oklahoma 74135
Not listed Portland Oregon 97210
Not listed Philadelphia Pennsylvania 19149
Not listed Charleston South Carolina 29407
Not listed Austin Texas 78756
Not listed Dallas Texas 75390
Not listed Salt Lake City Utah 84107
Not listed Bellevue Washington 98004
Not listed Seattle Washington 98104
Not listed Brown Deer Wisconsin 53223

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00245973, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 4, 2007 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00245973 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →